Literature DB >> 11090872

The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients.

C Jenkinson1, G Levvy, R Fitzpatrick, A Garratt.   

Abstract

OBJECTIVES: To evaluate response rate, data quality, and score reliability of the 40 item Amyotrophic Lateral Sclerosis Assessment Questionnaire in a survey of MND patients.
DESIGN: A survey of members of the MND Association of the UK, of which half were randomly allocated to receive a survey instrument from the MND Association and the other half allocated to receive the MND Association survey instrument and also the ALSAQ-40 questionnaire. SAMPLE: Five hundred patients were randomly selected from the membership lists of the MND Association, of whom 250 received the MND Association Survey and the ALSAQ-40.
RESULTS: Response rate to the survey was 59.2%. Over half of the respondents received the ALSAQ-40. Data for individual items were analysed and found to be distributed across all response categories. All items were found to be highly associated with the scales to which they contribute. Internal consistency reliability of all the five scales of the ALSAQ-40 was also found to be high.
CONCLUSION: Inclusion of the ALSAQ-40 into the survey did not have an adverse effect upon response rates. Furthermore, the ALSAQ-40 was shown to have highly desirable psychometric properties. This paper provides further evidence of the reliability and validity of the measure.

Entities:  

Mesh:

Year:  2000        PMID: 11090872     DOI: 10.1016/s0022-510x(00)00420-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Electronic pelvic floor symptoms assessment: tests of data quality of ePAQ-PF.

Authors:  G L Jones; S C Radley; J Lumb; S Jha
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-14

2.  Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  S Fadilah Abdul Wahid; Zhe Kang Law; Nor Azimah Ismail; Nai Ming Lai
Journal:  Cochrane Database Syst Rev       Date:  2019-12-19

Review 3.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

4.  Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.

Authors:  Josephine M Norquist; Ray Fitzpatrick; Crispin Jenkinson
Journal:  Qual Life Res       Date:  2004-10       Impact factor: 4.147

5.  Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).

Authors:  C Jenkinson; J M Norquist; R Fitzpatrick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

6.  Stakeholder Perspectives on the Biopsychosocial and Spiritual Realities of Living With ALS: Implications for Palliative Care Teams.

Authors:  Klaudia Kukulka; Karla T Washington; Raghav Govindarajan; David R Mehr
Journal:  Am J Hosp Palliat Care       Date:  2019-03-03       Impact factor: 2.500

7.  Validation of the Persian version of the 40-item amyotrophic lateral sclerosis assessment questionnaire.

Authors:  Hosein Shamshiri; Mohammad Reza Eshraghian; Nastaran Ameli; Shahriar Nafissi
Journal:  Iran J Neurol       Date:  2013

8.  A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.

Authors:  Tara Peseschkian; Isabell Cordts; René Günther; Benjamin Stolte; Daniel Zeller; Carsten Schröter; Ute Weyen; Martin Regensburger; Joachim Wolf; Ilka Schneider; Andreas Hermann; Moritz Metelmann; Zacharias Kohl; Ralf A Linker; Jan Christoph Koch; Boriana Büchner; Ulrike Weiland; Erik Schönfelder; Felix Heinrich; Alma Osmanovic; Thomas Klopstock; Johannes Dorst; Albert C Ludolph; Matthias Boentert; Tim Hagenacker; Marcus Deschauer; Paul Lingor; Susanne Petri; Olivia Schreiber-Katz
Journal:  Brain Sci       Date:  2021-03-14

9.  Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial).

Authors:  Satoru Morimoto; Shinichi Takahashi; Komei Fukushima; Hideyuki Saya; Norihiro Suzuki; Masashi Aoki; Hideyuki Okano; Jin Nakahara
Journal:  Regen Ther       Date:  2019-07-26       Impact factor: 3.419

Review 10.  Qualitative measures that assess functional disability and quality of life in ALS.

Authors:  Susan L Hartmaier; Thomas Rhodes; Suzanne F Cook; Courtney Schlusser; Chao Chen; Steve Han; Neta Zach; Venkatesha Murthy; Shreya Davé
Journal:  Health Qual Life Outcomes       Date:  2022-01-21       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.